Teikoku Seiyaku Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Higashikagawa Japan (1848)
Status: No NME R&D (1848)

Organization Overview

First Clinical Trial
2016
NCT02729207
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Teikoku Sayaku Co. Ltd. | Teikoku Seiyaku Co., Ltd.